Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 5
1966 5
1967 12
1968 5
1969 11
1970 11
1971 15
1972 22
1973 19
1974 46
1975 30
1976 50
1977 29
1978 28
1979 26
1980 13
1981 28
1982 29
1983 41
1984 26
1985 22
1986 21
1987 22
1988 18
1989 24
1990 20
1991 36
1992 24
1993 29
1994 24
1995 21
1996 23
1997 25
1998 28
1999 33
2000 25
2001 34
2002 32
2003 30
2004 40
2005 39
2006 51
2007 52
2008 51
2009 52
2010 48
2011 51
2012 63
2013 48
2014 51
2015 43
2016 53
2017 51
2018 46
2019 51
2020 51
2021 52
2022 45
2023 27
2024 11

Text availability

Article attribute

Article type

Publication date

Search Results

1,763 results

Results by year

Filters applied: . Clear all
Page 1
Non-invasive clinical and microscopic evaluation of the response to treatment with clobetasol cream vs. calcipotriol/betamethasone dipropionate foam in mild to moderate plaque psoriasis: an investigator-initiated, phase IV, unicentric, open, randomized clinical trial.
Yélamos O, Alejo B, Ertekin SS, Villa-Crespo L, Zamora-Barquero S, Martinez N, Domínguez M, Iglesias P, Herrero A, Malvehy J, Puig S. Yélamos O, et al. J Eur Acad Dermatol Venereol. 2021 Jan;35(1):143-149. doi: 10.1111/jdv.16559. Epub 2020 Jul 6. J Eur Acad Dermatol Venereol. 2021. PMID: 32365242 Free PMC article. Clinical Trial.
OBJECTIVES: To compare the clinical and non-invasive microscopic features in a psoriatic target lesion treated with clobetasol cream or calcipotriol/betamethasone dipropionate foam (Cal/BD foam). METHODS: Prospective, unicentric, open, randomized clinical trial comparing c …
OBJECTIVES: To compare the clinical and non-invasive microscopic features in a psoriatic target lesion treated with clobetasol cream or calc …
Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
Xia L, Li R, Wang Y, Lin Z, Zheng J, Li X, Lu Q, Zhang J, Jin H, Fu L, Zhang X, Liu Y, Yang S, Xiao F, Gao XH. Xia L, et al. Dermatol Ther. 2018 Sep;31(5):e12632. doi: 10.1111/dth.12632. Epub 2018 Sep 25. Dermatol Ther. 2018. PMID: 30253049 Clinical Trial.
To assess the efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment and calcipotriol/betamethasone dipropionate ointment in the treatment of mild-to-moderate patients with psoriasis vulgaris. ...All-trans retinoic acid/ …
To assess the efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment and calcipotriol/ …
Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India.
Jobe AH, Milad MA, Peppard T, Jusko WJ. Jobe AH, et al. Clin Transl Sci. 2020 Mar;13(2):391-399. doi: 10.1111/cts.12724. Epub 2019 Dec 13. Clin Transl Sci. 2020. PMID: 31808984 Free PMC article. Clinical Trial.
The 1:1 mixture of betamethasone phosphate and betamethasone acetate shows an immediate release of betamethasone followed by a slow release where plasma betamethasone can be measured out to 14 days after the single dose administration, likely from a de …
The 1:1 mixture of betamethasone phosphate and betamethasone acetate shows an immediate release of betamethasone follow …
Clinical, patient and estimated cost benefits of proactive management versus reactive management with calcipotriol/betamethasone dipropionate foam for the treatment of plaque psoriasis in Finland.
Harvima RJ, Gooderham M, Tyring S, Thoning H, Nyholm N, Stein Gold L. Harvima RJ, et al. J Dermatolog Treat. 2022 Jun;33(4):2234-2240. doi: 10.1080/09546634.2021.1942419. Epub 2021 Jul 7. J Dermatolog Treat. 2022. PMID: 34130573 Clinical Trial.
BACKGROUND: Proactive management of plaque psoriasis with twice-weekly topical calcipotriol/betamethasone dipropionate (Cal/BD) foam has a demonstrated clinical benefit in preventing disease relapse compared to reactive management, where Cal/BD foam is only given as rescue …
BACKGROUND: Proactive management of plaque psoriasis with twice-weekly topical calcipotriol/betamethasone dipropionate (Cal/BD) foam …
A prospective, double-blind, randomized clinical trial comparing subacromial injection of betamethasone and xylocaine to xylocaine alone in chronic rotator cuff tendinosis.
Alvarez CM, Litchfield R, Jackowski D, Griffin S, Kirkley A. Alvarez CM, et al. Am J Sports Med. 2005 Feb;33(2):255-62. doi: 10.1177/0363546504267345. Am J Sports Med. 2005. PMID: 15701612 Clinical Trial.
The injection into the subacromial space contained either 5 mL of 2% xylocaine alone or 4 mL of 2% xylocaine and 1 mL (6 mg) of betamethasone in an opaque syringe. RESULTS: In 58 patients (betamethasone group, n = 30; xylocaine group, n = 28), the authors found no s …
The injection into the subacromial space contained either 5 mL of 2% xylocaine alone or 4 mL of 2% xylocaine and 1 mL (6 mg) of betametha …
Significant efficacy of short-course, low-concentration betamethasone mouthwash therapy for severe erosive oral lichen planus: a randomized controlled trial.
Zeng Q, Liu Y, Wang S, Wang H, Yu S, Wu F, Yang J, Zhou H. Zeng Q, et al. Clin Oral Investig. 2023 Aug;27(8):4323-4334. doi: 10.1007/s00784-023-05051-w. Epub 2023 Jun 6. Clin Oral Investig. 2023. PMID: 37278917 Free PMC article. Clinical Trial.
OBJECTIVES: To evaluate the short-term efficacy of low-concentration betamethasone mouthwash for severe erosive oral lichen planus (EOLP). ...The primary outcome was the week-2 reduction in erosive area. RESULTS: Fifty-seven participants were randomized to betamethasone …
OBJECTIVES: To evaluate the short-term efficacy of low-concentration betamethasone mouthwash for severe erosive oral lichen planus (E …
Maternal and infant morbidity following administration of repeat dexamethasone or betamethasone prior to preterm birth: A secondary analysis of the ASTEROID Trial.
Hofer OJ, Harding JE, Tran T, Crowther CA. Hofer OJ, et al. PLoS One. 2022 Feb 22;17(2):e0263927. doi: 10.1371/journal.pone.0263927. eCollection 2022. PLoS One. 2022. PMID: 35192656 Free PMC article. Clinical Trial.
No randomised trials have assessed the efficacy of dexamethasone as a repeat steroid compared to betamethasone. AIM: We aimed to determine if there were differences between the use of dexamethasone or betamethasone as repeat ACS, for women who remain at risk of pret …
No randomised trials have assessed the efficacy of dexamethasone as a repeat steroid compared to betamethasone. AIM: We aimed to dete …
Long-Term Evaluation of Low-Dose Betamethasone for Ataxia Telangiectasia.
Hasegawa S, Kumada S, Tanuma N, Tsuji-Hosokawa A, Kashimada A, Mizuno T, Moriyama K, Sugawara Y, Shirai I, Miyata Y, Nishida H, Mashimo H, Hasegawa T, Hosokawa T, Hisakawa H, Uematsu M, Fujine A, Miyata R, Sakuma H, Kashimada K, Imai K, Morio T, Hayashi M, Mizutani S, Takagi M. Hasegawa S, et al. Pediatr Neurol. 2019 Nov;100:60-66. doi: 10.1016/j.pediatrneurol.2019.05.006. Epub 2019 May 13. Pediatr Neurol. 2019. PMID: 31272782 Clinical Trial.
Recent studies have demonstrated short-term improvement in neurological symptoms with betamethasone therapy. However, the long-term and adverse effects of betamethasone are unclear. ...After the cessation of betamethasone treatment, neurological symptoms wors …
Recent studies have demonstrated short-term improvement in neurological symptoms with betamethasone therapy. However, the long-term a …
A pharmacological and clinical comparison of prednisolone and betamethasone in rheumatoid arthritis.
Marwah RJ, Pickup ME, Al-Shakarchi H, Dixon JS, Lowe JR, Bird HA, Wright V. Marwah RJ, et al. Eur J Clin Pharmacol. 1982 Oct;23(4):321-5. doi: 10.1007/BF00613613. Eur J Clin Pharmacol. 1982. PMID: 7173301 Clinical Trial.
1. Two oral corticosteroids, prednisolone (8 mg/day) and betamethasone (1 mg/day) have been compared in terms of efficacy and adrenal suppressive activity when used in chronic oral dosage in rheumatoid arthritis. 2. 20 patients were entered to a single blind crossover stud …
1. Two oral corticosteroids, prednisolone (8 mg/day) and betamethasone (1 mg/day) have been compared in terms of efficacy and adrenal …
Fixed combination of tazarotene and betamethasone dipropionate for treatment of psoriasis vulgaris: The result of a phase 3, multicenter, randomized controlled trial.
Chen H, Sun J, Yang H, Sun Q, Zhang J, Gu J, Wen H, Li M, Liu X, Yang H, Lou D. Chen H, et al. J Dermatol. 2020 Jul;47(7):728-734. doi: 10.1111/1346-8138.15349. Epub 2020 Apr 28. J Dermatol. 2020. PMID: 32346959 Clinical Trial.
This study aimed to evaluate the clinical efficacy and safety of a fixed combination of TAZ 0.05% and betamethasone dipropionate 0.05% (BM) for psoriasis vulgaris. A multicenter, randomized, single-blinded, controlled phase 3 clinical trial was conducted. ...
This study aimed to evaluate the clinical efficacy and safety of a fixed combination of TAZ 0.05% and betamethasone dipropionate 0.05 …
1,763 results